As such, L1CAM is enriched in the invasive front of primary tumours, matched metastases, small cell-clusters invading lymphovascular vessels, and post-therapy surgical resection samples, implicating L1CAM in both metastasis and chemoresistance [166]. This evidence concerns the gene L1CAM and neoplasm.